The global medical aesthetics devices market size was US$ 10.8 billion in 2021. The global medical aesthetics devices market size is forecast to reach US$ 41.1 billion by 2030, growing at a compound annual growth rate (CAGR) of 15.9% during the forecast period from 2022 to 2030.
The purpose of medical aesthetic devices is to treat impairments related to the aesthetic appearance of a person, such as skin sagging, excess fat, cellulite, scars, moles, wrinkles, unwanted hair, liver spots, spider veins, and discoloration of the skin. In aesthetic medicine, physicians may use both surgical and non-surgical procedures to enhance a patient's appearance. The use of aesthetic implants may use to replace functional or missing body parts due to accidents, injuries, or congenital disorders.
Factors Influencing Market Growth
Impact Analysis of COVID-19
The COVID-19 pandemic has impacted the medical aesthetics device market adversely. Cosmetic and aesthetic device manufacturers had to shut down their worldwide production and supply units after a global lockdown imposed by the governments in order to control the spread of the virus during the outbreak of the COVID-19. Moreover, devices that have probes that come in contact with the skin, such as excimer lamps and skin-tightening devices, pose a high risk of transmitting the COVID-19 virus.
Regional Insights
North America captured the largest share of revenue in 2021. The number of people undergoing aesthetic procedures for enhancing aesthetics is growing rapidly in the United States. Numerous leading companies are actively competing in this market. Companies in this sector emphasize product innovation collaborations in order to grow the market share. Innovative technologies are becoming increasingly popular in the United States, presenting market leaders with great growth potential. Additionally, the growing prevalence of obesity in the region owing to sedentary lifestyles will be a high impact factor in the market growth in the region.
Leading Competitors
The leading prominent companies profiled in the global medical aesthetics devices market are:
Scope of the Report
The global medical aesthetics devices market segmentation focuses on Product, Application, End-User, and Region.
Segmentation based on Product
Segmentation based on Application
Segmentation based on End-User
Segmentation based on Region
[TABLE OF CONTENTS]
1 INTRODUCTION OF GLOBAL MEDICAL AESTHETICS DEVICES MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES
4 GLOBAL MEDICAL AESTHETICS DEVICES MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE MODEL
4.4 VALUE CHAIN ANALYSIS
5 GLOBAL MEDICAL AESTHETICS DEVICES MARKET, BY PRODUCT
5.1 OVERVIEW
5.2 DEVICES
5.2.1 AESTHETIC LASERS
5.2.1.1 ABLATIVE LASERS
5.2.1.2 NON-ABLATIVE LASERS
5.2.2 SKIN TIGHTENING & BODY CONTOURING DEVICES
5.2.2.1 LIPOSUCTION DEVICES
5.2.2.2 SKIN TIGHTENING DEVICES
5.2.2.3 CELLULITE REDUCTION DEVICES
5.3 AESTHETIC IMPLANTS
5.3.1 DENTAL IMPLANTS
5.3.1.1 ROOT FORM DENTAL IMPLANTS
5.3.1.2 PLATE FORM DENTAL IMPLANTS
5.3.2 BREAST IMPLANTS
5.3.2.1 SALINE FILLED
5.3.2.2 SILICONE GEL-FILLED
5.4 FACIAL IMPLANTS
5.5 OTHER IMPLANTS
6 GLOBAL MEDICAL AESTHETICS DEVICES MARKET, BY APPLICATION
6.1 OVERVIEW
6.2 SURGICAL
6.2.1 FACE & HEAD
6.2.1.1 BROW LIFT
6.2.1.2 EAR SURGERY
6.2.1.3 EYELID SURGERY
6.2.1.4 FACELIFT
6.2.1.5 FACIAL BONE CONTOURING
6.2.1.6 FACIAL FAT GRAFTING
6.2.1.7 NECK LIFT
6.2.1.8 HAIR TRANSPLANTATION
6.2.1.9 RHINOPLASTY
6.2.2 BREAST
6.2.2.1 BREAST AUGMENTATION
6.2.2.2 BREAST LIFT
6.2.3 BODY & EXTREMITIES
6.2.3.1 ABDOMINOPLASTY
6.2.3.2 BUTTOCK AUGMENTATION
6.2.3.3 BUTTOCK LIFT
6.2.3.4 LIPOSUCTION
6.2.3.5 LOWER BODY LIFT
6.2.3.6 PENILE ENLARGEMENT
6.2.3.7 THIGH LIFT
6.2.3.8 UPPER ARM LIFT
6.2.3.9 UPPER BODY LIFT
6.2.3.10 LABIAPLASTY
6.2.3.11 VAGINAL REJUVENATION
6.3 NON-SURGICAL
7 GLOBAL MEDICAL AESTHETICS DEVICES MARKET, BY END-USER
7.1 OVERVIEW
7.2 HOSPITALS & CLINICS
7.3 MEDICAL SPAS & BEAUTY CENTERS
8 GLOBAL MEDICAL AESTHETICS DEVICES MARKET, BY GEOGRAPHY
8.1 OVERVIEW
8.2 NORTH AMERICA
8.2.1 NORTH AMERICA MARKET SNAPSHOT
8.2.2 U.S.
8.2.3 CANADA
8.2.4 MEXICO
8.3 EUROPE
8.3.1 EUROPE MARKET SNAPSHOT
8.3.2 WESTERN EUROPE
8.3.2.1 THE UK
8.3.2.2 GERMANY
8.3.2.3 FRANCE
8.3.2.4 ITALY
8.3.2.5 SPAIN
8.3.2.6 REST OF WESTERN EUROPE
8.3.3 EASTERN EUROPE
8.3.3. 1 POLAND
8.3.3.2 RUSSIA
8.3.3.3 REST OF EASTERN EUROPE
8.4 ASIA PACIFIC
8.4.1 ASIA PACIFIC MARKET SNAPSHOT
8.4.2 CHINA
8.4.3 JAPAN
8.4.4 INDIA
8.4.5 AUSTRALIA & NEW ZEALAND
8.4.6 ASEAN
8.4.7 REST OF ASIA PACIFIC
8.5 MIDDLE EAST & AFRICA
8.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
8.5.2 UAE
8.5.3 SAUDI ARABIA
8.5.4 SOUTH AFRICA
8.5.5 REST OF MEA
8.6 SOUTH AMERICA
8.6.1 SOUTH AMERICA MARKET SNAPSHOT
8.6.2 BRAZIL
8.6.3 ARGENTINA
8.6.4 REST OF SOUTH AMERICA
9 GLOBAL MEDICAL AESTHETICS DEVICES MARKET COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 COMPANY MARKET RANKING
9.3 KEY DEVELOPMENT STRATEGIES
10 COMPANY PROFILES
10.1 ABBVIE INC. (ALLERGAN PLC)
10.1.1 OVERVIEW
10.1.2 FINANCIAL PERFORMANCE
10.1.3 PRODUCT OUTLOOK
10.1.4 KEY DEVELOPMENTS
10.2 ALMA LASERS LTD (SISRAM MED)
10.2.1 OVERVIEW
10.2.2 FINANCIAL PERFORMANCE
10.2.3 PRODUCT OUTLOOK
10.2.4 KEY DEVELOPMENTS
10.3 BAUSCH HEALTH COMPANIES INC. (SOLTA MEDICAL INC.)
10.3.1 OVERVIEW
10.3.2 FINANCIAL PERFORMANCE
10.3.3 PRODUCT OUTLOOK
10.3.4 KEY DEVELOPMENTS
10.4 CUTERA INC.
10.4.1 OVERVIEW
10.4.2 FINANCIAL PERFORMANCE
10.4.3 PRODUCT OUTLOOK
10.4.4 KEY DEVELOPMENTS
10.5 EL.EN. (ASCLEPION LASER TECHNOLOGIES)
10.5.1 OVERVIEW
10.5.2 FINANCIAL PERFORMANCE
10.5.3 PRODUCT OUTLOOK
10.5.4 KEY DEVELOPMENTS
10.6 CYNOSURE
10.6.1 OVERVIEW
10.6.2 FINANCIAL PERFORMANCE
10.6.3 PRODUCT OUTLOOK
10.6.4 KEY DEVELOPMENTS
10.7 LUMENIS INC.
10.7.1 OVERVIEW
10.7.2 FINANCIAL PERFORMANCE
10.7.3 PRODUCT OUTLOOK
10.7.4 KEY DEVELOPMENTS
10.8. SCITON INC.
10.8.1 OVERVIEW
10.8.2 FINANCIAL PERFORMANCE
10.8.3 PRODUCT OUTLOOK
10.8.4 KEY DEVELOPMENTS
10.9 SYNERON MEDICAL LTD
10.9.1 OVERVIEW
10.9.2 FINANCIAL PERFORMANCE
10.9.3 PRODUCT OUTLOOK
10.9.4 KEY DEVELOPMENTS
10.10 GALDERMA
10.10.1 OVERVIEW
10.10.2 FINANCIAL PERFORMANCE
10.10.3 PRODUCT OUTLOOK
10.10.4 KEY DEVELOPMENTS
10.11 JOHNSON & JOHNSON
10.11.1 OVERVIEW
10.11.2 FINANCIAL PERFORMANCE
10.11.3 PRODUCT OUTLOOK
10.11.4 KEY DEVELOPMENTS
10.12 MERZ PHARMA GMBH & CO. KGAA
10.12.1 OVERVIEW
10.12.2 FINANCIAL PERFORMANCE
10.12.3 PRODUCT OUTLOOK
10.12.4 KEY DEVELOPMENTS
We Accept
Copyright ©2022 All rights reserved
